These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12954055)

  • 1. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
    Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
    J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitors.
    Shen L; Prouty C; Conway BR; Westover L; Xu JZ; Look RA; Chen X; Beavers MP; Roberts J; Murray WV; Demarest KT; Kuo GH
    Bioorg Med Chem; 2004 Mar; 12(5):1239-55. PubMed ID: 14980636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.
    Zhang HC; Ye H; Conway BR; Derian CK; Addo MF; Kuo GH; Hecker LR; Croll DR; Li J; Westover L; Xu JZ; Look R; Demarest KT; Andrade-Gordon P; Damiano BP; Maryanoff BE
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3245-50. PubMed ID: 15149684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
    O'Neill DJ; Shen L; Prouty C; Conway BR; Westover L; Xu JZ; Zhang HC; Maryanoff BE; Murray WV; Demarest KT; Kuo GH
    Bioorg Med Chem; 2004 Jun; 12(12):3167-85. PubMed ID: 15158785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
    Ye Q; Xu G; Lv D; Cheng Z; Li J; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4302-12. PubMed ID: 19481464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of 7-azaindazolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors.
    Ye Q; Shen Y; Zhou Y; Lv D; Gao J; Li J; Hu Y
    Eur J Med Chem; 2013 Oct; 68():361-71. PubMed ID: 23994329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents.
    Ye Q; Mao W; Zhou Y; Xu L; Li Q; Gao Y; Wang J; Li C; Xu Y; Xu Y; Liao H; Zhang L; Gao J; Li J; Pang T
    Bioorg Med Chem; 2015 Mar; 23(5):1179-88. PubMed ID: 25662701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
    Tavares FX; Boucheron JA; Dickerson SH; Griffin RJ; Preugschat F; Thomson SA; Wang TY; Zhou HQ
    J Med Chem; 2004 Sep; 47(19):4716-30. PubMed ID: 15341487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Acylamino-6-arylfuro[2,3-d]pyrimidines: potent and selective glycogen synthase kinase-3 inhibitors.
    Maeda Y; Nakano M; Sato H; Miyazaki Y; Schweiker SL; Smith JL; Truesdale AT
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3907-11. PubMed ID: 15225695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors.
    Ye Q; Li M; Zhou YB; Cao JY; Xu L; Li YJ; Han L; Gao JR; Hu YZ; Li J
    Arch Pharm (Weinheim); 2013 May; 346(5):349-58. PubMed ID: 23585245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
    Zhang HC; White KB; Ye H; McComsey DF; Derian CK; Addo MF; Andrade-Gordon P; Eckardt AJ; Conway BR; Westover L; Xu JZ; Look R; Demarest KT; Emanuel S; Maryanoff BE
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3049-53. PubMed ID: 12941331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent and bioavailable GSK-3beta inhibitors.
    Gong L; Hirschfeld D; Tan YC; Heather Hogg J; Peltz G; Avnur Z; Dunten P
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1693-6. PubMed ID: 20138512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
    Shin D; Lee SC; Heo YS; Lee WY; Cho YS; Kim YE; Hyun YL; Cho JM; Lee YS; Ro S
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5686-9. PubMed ID: 17764934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: an insight into the criteria for selectivity.
    Dessalew N; Bharatam PV
    Eur J Med Chem; 2007 Jul; 42(7):1014-27. PubMed ID: 17335939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
    Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
    J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.
    Polychronopoulos P; Magiatis P; Skaltsounis AL; Myrianthopoulos V; Mikros E; Tarricone A; Musacchio A; Roe SM; Pearl L; Leost M; Greengard P; Meijer L
    J Med Chem; 2004 Feb; 47(4):935-46. PubMed ID: 14761195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors.
    Cho GW; Noh MY; Kang BY; Ku IW; Park J; Hong YH; Kim MH; Kim SH
    Assay Drug Dev Technol; 2011 Oct; 9(5):503-13. PubMed ID: 21561378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.
    Nemoto T; Yokoo H; Satoh S; Yanagita T; Sugano T; Yoshikawa N; Maruta T; Kobayashi H; Wada A
    Brain Res; 2006 Sep; 1110(1):1-12. PubMed ID: 16870161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of 3-(furo[2,3-b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides as Novel GSK-3β Inhibitors and Anti-Ischemic Agents.
    Ye Q; Li Q; Zhou Y; Xu L; Mao W; Gao Y; Li C; Xu Y; Xu Y; Liao H; Zhang L; Gao J; Li J; Pang T
    Chem Biol Drug Des; 2015 Oct; 86(4):746-52. PubMed ID: 25711384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR.
    Richardson CM; Williamson DS; Parratt MJ; Borgognoni J; Cansfield AD; Dokurno P; Francis GL; Howes R; Moore JD; Murray JB; Robertson A; Surgenor AE; Torrance CJ
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1353-7. PubMed ID: 16325401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.